SEC annual filings · Chemicals and Drugs

Which companies in chemicals and drugs have the most revenue in the SEC data we read?

In 2025, 221 companies in chemicals and drugs that have had revenue of 100 million dollars or more are ranked; Johnson & Johnson reported the most, $94.2 billion. The newest annual report in the data is for the fiscal year ended .

Revenue of the ten largest companies in chemicals and drugs, 2025

The largest first, each bar from zeroAs filed with the SEC

Revenue in 2025 of the ten largest companies in chemicals and drugs Johnson & Johnson: $94.2B; Procter & Gamble Co: $84.3B; Eli Lilly & Co: $65.2B; Merck & Co., Inc.: $65.0B; Pfizer Inc: $62.6B; AbbVie Inc.: $61.2B; Bristol-Myers Squibb Co: $48.2B; Abbott Laboratories: $44.3B; DOW Inc.: $40.0B; Amgen Inc: $36.8B Johnson & Johnson $94.2B Procter & Gamble Co $84.3B Eli Lilly & Co $65.2B Merck & Co., Inc. $65.0B Pfizer Inc $62.6B AbbVie Inc. $61.2B Bristol-Myers Squibb Co $48.2B Abbott Laboratories $44.3B DOW Inc. $40.0B Amgen Inc $36.8B Revenue in 2025 of the ten largest companies in chemicals and drugs Johnson & Johnson: $94.2B; Procter & Gamble Co: $84.3B; Eli Lilly & Co: $65.2B; Merck & Co., Inc.: $65.0B; Pfizer Inc: $62.6B; AbbVie Inc.: $61.2B; Bristol-Myers Squibb Co: $48.2B; Abbott Laboratories: $44.3B; DOW Inc.: $40.0B; Amgen Inc: $36.8B Johnson & Johnson $94.2B Procter & Gamble Co $84.3B Eli Lilly & Co $65.2B Merck & Co., Inc. $65.0B Pfizer Inc $62.6B AbbVie Inc. $61.2B Bristol-Myers Squibb Co $48.2B Abbott Laboratories $44.3B DOW Inc. $40.0B Amgen Inc $36.8B

Each bar is the revenue of one company for its fiscal year in 2025, as it filed it. The whole ranking is under "The numbers behind the chart".

Observed .

Right now

Johnson & Johnson reported the most revenue in 2025, $94.2 billion.

221 companies in chemicals and drugs are ranked for 2025.

See the ranked companies of the group

Share of revenueOurs

Together they reported $1.2 trillion of revenue, 4.6% of the revenue of all $25.7 trillion reported by the ranked companies.

A fiscal year is counted in the calendar year most of its days fall in, as the SEC labels it, so a year that ended on 31 January 2026 is 2025 here; the market totals count a year in the year it ends in, so their sum for the same year holds other fiscal years.

As filed

Facts as filed with the SEC, and our arithmetic on them. Not investment advice.

Total assets are the figure the SEC data holds for the fiscal year end.

Understanding the ranking

Where it stands today

Johnson & Johnson reported $94.2 billion, the most in 2025.

How is the ranking made?

The ranking lists companies by the revenue they filed with the SEC for their fiscal year in 2025, the largest first.

Read more

A company is in the ranking when its latest annual report shows revenue of 100 million dollars or more, and stays in it afterwards. A company that has stopped filing keeps its page and is not ranked.

The numbers behind the chart

Which companies in chemicals and drugs reported the most revenue?221 companies
Companies by revenue in 2025, the largest first (dollars as filed)
CompanyRankSymbolRevenueProfit or lossTotal assets
Johnson & Johnson1JNJ$94.2B$26.8B$199B
Procter & Gamble Co2PG$84.3B$16.0B$125B
Eli Lilly & Co3LLY$65.2B$20.6B$112B
Merck & Co., Inc.4MRK$65.0B$18.3B$137B
Pfizer Inc5PFE$62.6B$7.77B$208B
AbbVie Inc.6ABBV$61.2B$4.23B$134B
Bristol-Myers Squibb Co7BMY$48.2B$7.05B$90.0B
Abbott Laboratories8ABT$44.3B$6.52B$86.7B
DOW Inc.9DOW$40.0B–$58.5B
Amgen Inc10AMGN$36.8B$7.71B$90.6B
Linde plc11LIN$34.0B$6.90B$86.8B
LyondellBasell Industries N.V.12LYB$30.2B−$738M$34.0B
Gilead Sciences, Inc.13GILD$29.4B$8.51B$59.0B
Colgate-Palmolive Co14CL$20.4B$2.13B$16.3B
Teva Pharmaceutical Industries Ltd15TEVA$17.3B$1.41B$40.7B
Ecolab Inc.16ECL$16.1B$2.08B$24.7B
PPG Industries Inc17PPG$15.9B$1.58B$22.1B
Kenvue Inc.18KVUE$15.1B$1.47B$27.1B
Regeneron Pharmaceuticals, Inc.19REGN$14.3B$4.50B$40.6B
Estee Lauder Companies Inc20EL$14.3B−$1.13B$19.9B
Viatris Inc21VTRS$14.3B–$37.2B
Mosaic Co22MOS$12.1B$541M$24.5B
Air Products & Chemicals, Inc.23APD$12.0B−$395M$41.1B
Vertex Pharmaceuticals Inc24VRTX$12.0B$3.95B$25.6B
Westlake Corp25WLK$11.2B−$1.51B$20.0B
Show 196 more rows
Companies by revenue in 2025, the largest first (dollars as filed) (continued)
CompanyRankSymbolRevenueProfit or lossTotal assets
International Flavors & Fragrances Inc26IFF$10.9B–$25.5B
Bausch Health Companies Inc.27BHC$10.3B$157M$26.4B
Biogen Inc.28BIIB$9.89B$1.29B$29.4B
Celanese Corp29CE$9.54B−$1.17B$21.7B
Zoetis Inc.30ZTS$9.47B$2.67B$15.5B
Eastman Chemical Co31EMN$8.75B$474M$14.9B
RPM International Inc32RPM$7.86B$662M$8.34B
Clorox Co33CLX$7.10B$824M$5.56B
CF Industries Holdings, Inc.34CF$7.08B–$14.1B
DuPont de Nemours, Inc.35DD$6.85B$88.0M$21.6B
Olin Corp36OLN$6.78B−$101M$7.33B
Organon & Co.37OGN$6.22B$187M$12.9B
Church & Dwight Co Inc38CHD$6.20B$737M$8.91B
Coty Inc.39COTY$5.89B−$381M$11.9B
Chemours Co40CC$5.81B−$386M$7.38B
Huntsman Corp41HUN$5.68B−$284M$7.01B
Sealed Air Corp42–$5.36B$506M$7.01B
BeOne Medicines Ltd.43ONC$5.34B$287M$8.19B
Albemarle Corp44ALB$5.14B−$511M$16.4B
Axalta Coating Systems Ltd.45AXTA$5.12B$379M$7.60B
Elanco Animal Health Inc46ELAN$4.71B−$232M$13.4B
IDEXX Laboratories Inc47IDXX$4.30B$1.06B$3.35B
Jazz Pharmaceuticals plc48JAZZ$4.27B−$356M$11.7B
Perrigo Co plc49PRGO$4.25B−$1.43B$8.54B
Union Carbide Corp50–$3.99B$560M$4.52B
Solstice Advanced Materials Inc.51SOLS$3.89B$237M$5.67B
Alnylam Pharmaceuticals, Inc.52ALNY$3.71B$314M$4.97B
Cabot Corp53CBT$3.71B$331M$3.81B
Fuller H B Co54FUL$3.47B$152M$5.18B
FMC Corp55FMC$3.47B−$2.24B$9.69B
Scotts Miracle-Gro Co56SMG$3.41B$145M$2.74B
Avient Corp57AVNT$3.26B$81.9M$6.03B
BioMarin Pharmaceutical Inc58BMRN$3.22B$349M$7.59B
United Therapeutics Corp59UTHR$3.18B$1.33B$7.88B
Amneal Pharmaceuticals, Inc.60AMRX$3.02B$72.1M$3.68B
Trinseo plc61TSEOQ$2.97B−$546M$2.28B
Tronox Holdings plc62TROX$2.90B−$470M$6.22B
Neurocrine Biosciences Inc63NBIX$2.86B$479M$4.63B
QuidelOrtho Corp64QDEL$2.73B–$5.77B
NewMarket Corp65NEU$2.73B$419M$3.49B
Element Solutions Inc66ESI$2.55B$191M$5.10B
Royalty Pharma plc67RPRX$2.38B$771M$19.6B
Stepan Co68SCL$2.33B$46.9M$2.36B
Exelixis, Inc.69EXEL$2.32B$783M$2.84B
Sarepta Therapeutics, Inc.70SRPT$2.20B−$713M$3.35B
Green Plains Inc.71GPRE$2.09B−$121M$1.58B
Qiagen N.V.72QGEN$2.09B$425M$6.28B
Valhi Inc73VHI$2.08B−$57.6M$2.63B
Minerals Technologies Inc74MTX$2.07B−$18.4M$3.47B
Edgewell Personal Care Co75EPC$1.96B$25.4M$3.76B
Moderna, Inc.76MRNA$1.94B−$2.82B$12.3B
Hexcel Corp77HXL$1.89B$109M$2.70B
Kronos Worldwide Inc78KRO$1.86B−$111M$1.82B
Orion S.A.79OEC$1.81B−$70.0M$1.91B
Innospec Inc.80IOSP$1.78B–$1.83B
PTC Therapeutics, Inc.81PTCT$1.73B$683M$2.90B
e.l.f. Beauty, Inc.82ELF$1.64B$26.3M$2.39B
Sensient Technologies Corp83SXT$1.61B$134M$2.24B
Lantheus Holdings, Inc.84LNTH$1.54B$234M$2.23B
AdvanSix Inc.85ASIX$1.52B$49.3M$1.71B
Interparfums Inc86IPAR$1.49B$208M$1.59B
Alkermes plc.87ALKS$1.48B$242M$2.49B
Keenova Therapeutics plc88–$1.43B−$490M$5.63B
Halozyme Therapeutics, Inc.89HALO$1.40B$317M$2.53B
Phibro Animal Health Corp90PAHC$1.30B$48.3M$1.36B
Curaleaf Holdings, Inc.91CURLF$1.27B−$231M$2.85B
Indivior Pharmaceuticals, Inc.92INDV$1.24B$210M$1.20B
Bio-Techne Corp93TECH$1.22B$73.4M$2.56B
Trulieve Cannabis Corp.94TRLV$1.18B−$116M$2.70B
Ingevity Corp95NGVT$1.17B−$167M$1.65B
Westlake Chemical Partners LP96WLKP$1.17B$48.7M$1.26B
Novavax Inc97NVAX$1.12B$440M$1.18B
Prestige Consumer Healthcare Inc.98PBH$1.09B$190M$3.49B
CSW Industrials, Inc.99CSW$1.08B$112M$2.32B
Acadia Pharmaceuticals Inc100ACAD$1.07B$391M$1.56B
Balchem Corp101BCPC$1.04B$155M$1.69B
Apellis Pharmaceuticals, Inc.102–$1.00B$22.4M$1.08B
Ionis Pharmaceuticals Inc103IONS$944M−$381M$3.52B
USANA Health Sciences Inc104USNA$925M$10.8M$743M
Alto Ingredients, Inc.105ALTO$918M–$389M
Tilray Brands, Inc.106TLRY$915M−$121M$2.33B
ANI Pharmaceuticals Inc107ANIP$883M$78.0M$1.44B
BioCryst Pharmaceuticals Inc108BCRX$875M$264M$514M
Neogen Corp109NEOG$870M−$7.90M$3.35B
Harmony Biosciences Holdings, Inc.110HRMY$868M$159M$1.27B
Myriad Genetics Inc111MYGN$825M−$366M$707M
Rogers Corp112ROG$811M−$61.8M$1.43B
Oddity Tech Ltd113ODD$810M$111M$1.14B
Collegium Pharmaceutical, Inc114COLL$781M$63.0M$1.66B
Corcept Therapeutics Inc115CORT$761M$99.7M$837M
Emergent BioSolutions Inc.116EBS$743M$52.6M$1.32B
Repligen Corp117RGEN$738M$48.9M$2.95B
Pacira BioSciences, Inc.118PCRX$726M$7.00M$1.26B
Ecovyst Inc.119ECVT$724M−$71.1M$1.26B
Amphastar Pharmaceuticals, Inc.120AMPH$720M$98.1M$1.63B
Supernus Pharmaceuticals, Inc.121SUPN$719M−$38.6M$1.45B
Kiniksa Pharmaceuticals International, plc122KNSA$678M$59.0M$764M
Ultragenyx Pharmaceutical Inc.123RARE$673M−$575M$1.53B
Cresco Labs Inc.124CRLBF$656M−$135M$1.20B
Perimeter Solutions, Inc.125PRM$653M−$206M$2.65B
REX American Resources Corp126REX$650M$83.0M$798M
Axsome Therapeutics, Inc.127AXSM$638M−$183M$690M
Amicus Therapeutics, Inc.128–$634M−$27.1M$950M
WD-40 Co129WDFC$620M$91.0M$476M
TG Therapeutics, Inc.130TGTX$616M$447M$1.06B
LSB Industries, Inc.131LXU$615M$24.6M$1.17B
Yatsen Holding Ltd132YSG$615M−$11.6M$550M
OPKO Health, Inc.133OPK$607M−$226B$1.93B
Insmed Inc134INSM$606M−$1.28B$2.26B
CVR Partners, LP135UAN$606M$98.7M$969M
Catalyst Pharmaceuticals, Inc.136–$589M$214M$1.10B
Organogenesis Holdings Inc.137ORGO$564M$37.0M$599M
HUTCHMED (China) Ltd138HCM$549M$457M$1.75B
Mirum Pharmaceuticals, Inc.139MIRM$521M−$23.4M$843M
American Vanguard Corp140AVD$515M−$49.9M$597M
ADMA Biologics, Inc.141ADMA$510M$147M$624M
BridgeBio Pharma, Inc.142BBIO$502M–$936M
Ascend Wellness Holdings, Inc.143AAWH$501M–$908M
Travere Therapeutics, Inc.144TVTX$491M−$25.5M$605M
Nature's Sunshine Products Inc145NATR$480M$19.5M$261M
Zai Lab Ltd146ZLAB$460M−$176M$1.17B
Tarsus Pharmaceuticals, Inc.147TARS$451M−$66.0M$562M
Olaplex Holdings, Inc.148–$423M−$9.25M$1.50B
Innoviva, Inc.149INVA$411M–$1.64B
Ardelyx, Inc.150ARDX$407M−$62.0M$502M
Esperion Therapeutics, Inc.151–$403M−$22.7M$466M
Immunocore Holdings plc152IMCR$400M−$35.5M$1.07B
Krystal Biotech, Inc.153KRYS$389M$205M$1.33B
Sinovac Biotech Ltd154SVA$386M–$8.54B
Luxfer Holdings plc155LXFR$385M$7.70M$370M
Twist Bioscience Corp156TWST$377M−$77.7M$642M
Arcutis Biotherapeutics, Inc.157ARQT$376M−$16.1M$433M
MannKind Corp158MNKD$349M$5.86M$792M
Evolus, Inc.159EOLS$297M−$51.6M$226M
Ironwood Pharmaceuticals Inc160IRWD$296M$24.0M$397M
Rigel Pharmaceuticals Inc161RIGL$294M–$514M
Xeris Biopharma Holdings, Inc.162XERS$292M–$384M
Aurinia Pharmaceuticals Inc.163AUPH$283M–$752M
Adaptive Biotechnologies Corp164ADPT$277M−$59.5M$513M
Vericel Corp165VCEL$276M$16.5M$488M
Harrow, Inc.166HROW$272M−$5.14M$399M
Waldencast plc167MLKMF$272M−$230M$746M
Vireo Growth Inc.168VREOF$269M−$68.1M$817M
Ligand Pharmaceuticals Inc169LGND$268M$124M$1.56B
Jushi Holdings Inc.170JUSH$263M−$68.6M$422M
Arvinas, Inc.171ARVN$263M−$81.0M$718M
Schrodinger, Inc.172SDGR$256M−$103M$726M
Arcus Biosciences, Inc.173RCUS$247M−$353M$1.14B
Flotek Industries Inc174FTK$237M$30.5M$220M
Vaxart, Inc.175VXRT$237M–$186M
Akebia Therapeutics, Inc.176AKBA$236M−$5.30M$377M
AnaptysBio, Inc177ANAB$235M−$13.2M$364M
Lifevantage Corp178LFVN$229M$9.80M$72.0M
Puma Biotechnology, Inc.179PBYI$228M$31.1M$216M
IDEAYA Biosciences, Inc.180IDYA$219M−$114M$1.11B
Vanda Pharmaceuticals Inc.181VNDA$216M−$221M$489M
Amarin Corp plc182AMRN$214M−$38.8M$671M
Aemetis, Inc183AMTX$198M−$77.0M$260M
Cronos Group Inc.184CRON$193M−$2.90M$1.20B
biote Corp.185BTMD$192M$27.0M$108M
Rhythm Pharmaceuticals, Inc.186RYTM$190M−$0.20M$480M
Maravai Lifesciences Holdings, Inc.187MRVI$186M−$131M$771M
Stoke Therapeutics, Inc.188STOK$184M−$6.88M$418M
Glass House Brands Inc.189GLAS$182M−$29.7M$319M
Cryoport, Inc.190CYRX$176M$78.3M$765M
Phathom Pharmaceuticals, Inc.191PHAT$175M–$259M
Syndax Pharmaceuticals Inc192SNDX$172M−$285M$530M
REGENXBIO Inc.193RGNX$170M−$194M$453M
Ginkgo Bioworks Holdings, Inc.194DNA$170M−$0.31M$1.12B
Gevo, Inc.195GEVO$161M−$33.8M$719M
MariMed Inc.196MRMD$160M−$14.5M$203M
Liquidia Corp197LQDA$158M−$68.9M$328M
NLI Holdings, Inc.198NL$158M−$37.8M$464M
Day One Biopharmaceuticals, Inc.199–$158M−$107B$508M
Heron Therapeutics, Inc.200HRTX$155M−$20.0M$256M
MacroGenics Inc201MGNX$150M–$257M
Elite Pharmaceuticals Inc202ELTP$149M$44.9M$138M
Karyopharm Therapeutics Inc.203KPTI$146M−$196M$108M
Highwater Ethanol LLC204–$141M$16.3M$89.9M
Beam Therapeutics Inc.205BEAM$140M−$80.0M$1.48B
Natural Alternatives International Inc206NAII$130M−$13.6M$152M
Niagen Bioscience, Inc.207NAGE$129M$17.4M$106M
Xencor Inc208XNCR$126M−$91.9M$875M
Monte Rosa Therapeutics, Inc.209GLUE$124M−$38.6M$449M
Atara Biotherapeutics, Inc.210ATRA$121M$32.7M$20.2M
Arq, Inc.211ARQ$120M−$52.6M$231M
Assertio Holdings, Inc.212–$119M−$30.4M$267M
Gyre Therapeutics, Inc.213GYRE$117M$9.88M$220M
Agenus Inc214AGEN$114M−$3.08M$227M
UroGen Pharma Ltd.215URGN$110M−$153M$200M
Century Therapeutics, Inc.216IPSC$109M−$9.58M$224M
Mannatech Inc217MTEX$108M−$15.2M$30.0M
Theravance Biopharma, Inc.218–$107M$106M$486M
Zevra Therapeutics, Inc.219ZVRA$106M$83.2M$285M
Zymeworks Inc.220ZYME$106M−$81.1M$347M
Sutro Biopharma, Inc.221STRO$102M−$191M$174M

The table scrolls sideways; the first column stays in place.

Which other companies does the group hold?2 companies
What does the ranking leave out, and where is it from?Limits and source

What this number cannot tell you

  • Only companies with a revenue figure for the ranking year that passes our checks are ranked, the largest first; equal figures share a rank.
  • A company's figures are its own. A company that files together with a parent or a subsidiary is ranked on its own figure, so the same business can appear twice, and a sum of revenue counts it twice.
  • Total assets are shown only when the SEC data dates them within ten days of the fiscal year end, and profit only when its period ends within sixty days of it.
  • A dash is a gap. Either the company did not report that figure for that year, or the figure failed one of our checks and is not shown. The dash says which when it is pointed at.

Observed .

Page updated